Showing results (71-80 of 125) with videos related to

Sort By:
Pageof 13
Human & Experimental Toxicology|May 1, 1990
The effects of charcoal and sorbitol (alone and in combination) on plasma theophylline concentrations after a sustained-release formulationA H al-Shareef, D C Buss, E M Allen, et al.
British Journal of Clinical Pharmacology|November 1, 1989
Bioavailability of intranasal metoclopramideM J Ward, D C Buss, J Ellershaw, et al.
Clinical Pharmacology and Therapeutics|August 1, 1981
Relationship between alpha 1-acid glycoprotein and lidocaine disposition in myocardial infarctionP A Routledge, D G Shand, A Barchowsky, et al.
American Heart Journal|November 1, 1981
Clinical comparison of rapid infusion and multiple injection methods for lidocaine loadingW W Stargel, D G Shand, P A Routledge, et al.
Journal of Accident & Emergency Medicine|February 25, 1998
The impact of nationally distributed guidelines on the management of paracetamol poisoning in accident and emergency departments. National Poison Information ServiceM C Bialas, R J Evans, A D Hutchings, et al.
British Journal of Clinical Pharmacology|January 1, 1979
Mean steady-state plasma concentrations of labetalol in patients undergoing antihypertensive therapyG L Sanders, P A Routledge, A Ward, et al.
British Journal of Clinical Pharmacology|February 1, 1985
The effects of age and smoking on the plasma protein binding of lignocaine and diazepamD Davis, S H Grossman, B B Kitchell, et al.
Clinical Pharmacology and Therapeutics|March 1, 1980
Lidocaine plasma protein bindingP A Routledge, A Barchowsky, T D Bjornsson, et al.
British Journal of Clinical Pharmacology|December 5, 2015
Mean steady-state plasma concentrations of labetalol in patients undergoing antihypertensive therapyG L Sanders, P A Routledge, A Ward, et al.
Clinical Pharmacology and Therapeutics|March 1, 1982
Diazepam and lidocaine plasma protein binding in renal diseaseS H Grossman, D Davis, B B Kitchell, et al.
Pageof 13